4//SEC Filing
Evanson Jeff 4
Accession 0001415889-24-007516
CIK 0001649989other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:43 PM ET
Size
5.3 KB
Accession
0001415889-24-007516
Insider Transaction Report
Form 4
Evanson Jeff
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2024-03-07$0.42/sh+62,484$26,243→ 808,459 total
Footnotes (1)
- [F1]The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.4044 to $0.42 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001760511
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 4:43 PM ET
- Size
- 5.3 KB